Investing.com UK - Financial Markets Worldwide
Get 40% Off
Get 40% Off
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list

Futura Medical (FUM)

London
Currency in GBP
Disclaimer
35.65
+0.15(+0.42%)
Closed

FUM Price Commentary

2 November 2023 Futura Medical plc ("Futura" or the "Company") Eroxon Awarded "New Product of the Year, Healthcare" by Boots
2 Nov 2023 15:34 RNS Number : 2422S Futura Medical PLC 02 November 2023 2 November 2023 Futura Medical plc ("Futura" or the "Company") Eroxon Awarded "New Product of the Year, Healthcare" by Boots Futura Medical plc (AIM: FUM) ("Futura" or the "Company"), the pharmaceutical company developing innovative sexual health products, announces that Eroxon® has won the "New Product of the Year, Healthcare" category at the Boots Supplier Awards 2023, following its UK launch earlier this year. The award is further recognition for Futura's breakthrough treatment for erectile dysfunction ("ED") as it provides an alternative treatment option for the 4.3 million men in the UK experiencing symptoms*.
What the heck has happened to this share? Was doing ok and then it's just dropped over 50%
This going steadily climb then explode in price on 27th...... profits will pay my gas bill 💵 this winter 🥶
US trial results due anytime now. There seems to be some anticipation building in the stock chart trend.
Any news on why the EU Approval Certification is taking so long?
covid restrictions apply and hampper testing facilities no doubt
EU UK approval is in place. Now in the commercialisation phase.
(LON:FUM) AGM Statement from the pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology and currently focused on sexual health and pain. MED3000 CE mark approved for marketing in Europe and UK; Commercialisation of MED3000 continues at pace with China and South East Asia partnered and discussions for other countries ongoing;
More positive news today
will this not go up again until we see revenues start to come in, which could be months?
thanks, i bought in near the top so i am trying to work out where the bottom is to lower my average, but it looks like it could go back to the 40s. maybe i will get a bit more at 50
Possibly may go into the late 40’s. Would be a good entry point if it goes. I can honestly see this up near £1 in the next few months. Time will tell. Good luck
Time did tell. 😢
will pull back down
why? any news?
100p soon! Buy!
this is going to rise & rise !!
no pun intended :)
very positive about this company.
Good idea on the erectile dysfunction gel
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.